Elvie Further Expands Access To Its Innovative Technology With Retail Launch Of Elvie Stride Plus

Based on consumer demand, Elvie is bringing its newest innovation to retailers across the country

Elvie, the revolutionary global femtech innovator, announces the launch of Elvie Stride Plus, featuring the award-winning breast pump, Elvie Stride, along with a 3-in-1 Carry Bag.

Elvie Stride Plus will provide more women access to its innovative breast pumping solutions. The waitlist opens today, March 21, and Elvie Stride Plus will be available to order on April 20 on Elvie.com. This announcement follows the successful Elvie Stride launch into the healthcare channel in 2021, which sold out within two weeks of launch.

Elvie Stride Plus is a hands-free, hospital-grade electric breast pump, with 3-in-1 Carry Bag. This award-winning breast pump connects to the Pump with Elvie app and allows users to track their pumping history and control the pump from their phone. The 3-in-1 Carry Bag comes with a wet bag for mess-free travel, a cool bag and an ice pack to keep breast milk fresh. The bag is also compatible with standard 5 oz milk storage bottles and bags (sold separately). Previously, Elvie Stride was only available through insurance; now consumers have the opportunity to purchase this game-changing breast pump at Elvie.com.

“When we launched Elvie Stride six months ago, we were thrilled to hear women rave about how Elvie Stride changed their lives through its technology and performance, especially for the value and during a time when women are taking on so much more responsibility,” said Tania Boler, founder, and CEO of Elvie. “We know how challenging it is to find high-performing products packaged all together. By creating an all-inclusive carrying system and offering it for purchase directly, we’re one step closer to filling the innovation gap in technology for women.”

Elvie continues to expand its product line and innovate new solutions for more women to have access to products that work smarter and harder for their bodies. Elvie’s category leadership has been recognized by industry titans; most recently, Elvie Stride won the 2021 TIME Best Invention Award for its product design, innovation and accessibility. The new launch follows Elvie’s latest campaign, Smart Bodies, unveiled on International Women’s Day. Featuring multi-genre artist Eva Lazarus, the campaign celebrates women’s bodies for their complexities beyond their aesthetic value and highlights how Elvie is providing women with the technology their bodies deserve. More here.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”